Fig. 1From: Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapyCommon carotid artery peak and mean wall shear stress in the Empagliflozin group (a) and the Control group (b). *p for trend. Bonferroni post hoc analysis: τP baseline vs 1- and 3-month p = 0.03; τM baseline vs 1-month p = 0.04, baseline vs 3-month < 0.01Back to article page